(Q40392973)

20 September 2017

1 reference

title

Impaired proliferation and differentiation of myelodysplastic CD34+ cells (English)

1 reference

20 September 2017

Impaired Proliferation and Differentiation of Myelodysplastic CD34+Cells (English)

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

16 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522720

16 May 2024

author name string

K. Sawada

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522720

16 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7522720

16 May 2024

publication date

1 June 1994

1 reference

full work available at URL

20 September 2017

http://www.tandfonline.com/doi/pdf/10.3109/10428199409049649

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

16 May 2024

1 reference

20 September 2017

volume

14

1 reference

20 September 2017

issue

1-2

1 reference

20 September 2017

page(s)

37-47

1 reference

The preleukemic syndrome: correlation of in vitro parameters of granulopoiesis with clinical features

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Pancytopenia as a clonal disorder of a multipotent hematopoietic stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Proposals for the classification of the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors. Mechanism for the hematopoietic response to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Single cell origin of multilineage colonies in culture. Evidence that differentiation of multipotent progenitors and restriction of proliferative potential of monopotent progenitors are stochastic processes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Activated Protein Kinase C Directly Phosphorylates the CD34 Antigen in Acute Lymphoblastic Leukemia Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Purification and characterization of mouse hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Phase I study of recombinant human interleukin-3 in patients with bone marrow failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Contrasting patterns of neoplastic cell behaviour in long-term culture of bone marrow from patients with acute leukaemia and myelodysplastic disorders. A survey of responses in 31 cases with cytogenetic determination of neoplastic status of cultured

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Subgroups of oligoleukemia as identified by in vitro agar culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

In vitro agar culture patterns in preleukemia and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Granulocyte and monocyte surface membrane markers in the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Myeloid surface antigen abnormalities in myelodysplasia: relation to prognosis and modification by 13-cis retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Mutations of the Kirsten-ras proto-oncogene in human preleukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Characterization of clonogenic cells in refractory anemia with excess of blasts (RAEB-CFU): response to recombinant hematopoietic growth factors and maturation phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

A common progenitor for human myeloid and lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049649

Preleukemia. The hematologic syndrome preceding acute leukemia

21 January 2018

1

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

16 May 2024

Human preleukemia

3

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Myelodysplastic syndrome (MDS)-associated inhibitory activity on haemopoietic progenitor cells

16 May 2024

12

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Restoration of in vitro hematopoiesis in B-chronic lymphocytic leukemia by antibodies to tumor necrosis factor

16 May 2024

13

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Proliferation and differentiation of myelodysplastic CD34+ cells in serum‐free medium: response to individual colony‐stimulating factors

16 May 2024

14

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Expression of CD34 on human B cell precursors

16 May 2024

22

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Sequential expression of CD34 and CD33 antigens on myeloid colony-forming cells

16 May 2024

31

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study

16 May 2024

36

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Expression of haematopoietic progenitor cell-associated antigen BI-3C5/CD34 in leukemia

16 May 2024

39

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy

16 May 2024

40

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

The nature of blast cells in myelodysplastic syndromes evolving to acute leukaemia

16 May 2024

41

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Myelodysplastic syndromes: a study of surface markers and in vitro growth patterns

16 May 2024

42

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Identification of a membrane glycoprotein associated with haemopoietic progenitor cells

16 May 2024

43

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors

16 May 2024

54

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Circulating erythropoietin in patients with myelodysplastic syndromes

16 May 2024

57

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Limiting dilution analysis of the cells of immune system I. The clonal basis of the immune response

16 May 2024

59

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Enrichment of haemopoietic progenitor cells from the marrow of patients with myelodysplasia

16 May 2024

60

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Complete replacement of serum in primary cultures of erythropoietin-dependent red cell precursors (CFU-E) by albumin, transferrin, iron, unsaturated fatty acid, lecithin and cholesterol

16 May 2024

61

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report

16 May 2024

66

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes

16 May 2024

69

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Human preleukemia. Identification of a maturation defect in vitro

16 May 2024

79

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

The myeloproliferative disorders. Correlation between clinical evolution and alterations of granulopoiesis

16 May 2024

85

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Prognostic Value of in Vitro Bone Marrow Culture in Refractory Anaemia with Excess of Myeloblasts

16 May 2024

86

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Prognostic value of the combined suicide level of granulocyte progenitors and the labelling index of precursors in preleukemic states and oligoblastic leukemias

16 May 2024

90

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

In vitro growth pattern and differentiation predict for progression of myelodysplastic syndromes to acute nonlymphocytic leukaemia

16 May 2024

91

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Maturation of human acute myeloid leukaemia in vitro: the response to five recombinant haematopoietic factors in a serum-free system

16 May 2024

96

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Analysis of leucocyte differentiation antigens in blood and bone marrow in patients with refractory anaemia (RA) and RA with sideroblasts. Prognostic implications of sequential and follow-up data.

16 May 2024

99

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes

16 May 2024

100

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

In vitro effects of recombinant hemopoietic growth factors on progenitor cells from patients with myelodysplastic syndromes

16 May 2024

101

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Circulating CD34+ cells: an adverse prognostic factor in the myelodysplastic syndromes

16 May 2024

106

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

Transitional change of colony stimulating factor requirements for erythroid progenitors

16 May 2024

114

1 reference

https://api.crossref.org/works/10.3109/10428199409049649

16 May 2024

Identifiers

1 reference

20 September 2017

1 reference